WERENNE, J. (1982). L'Interféron: perspectives actuelles. Ann. Méd. Vét. 126, 93–122.
WEISSMANN, C. (1981). The cloning of interferon and other mistakes. Interferon 3, 101–134.
NAGATA, S., TAIRA, H., HALL, A., JOHNSRUD, L., STREULI, M., ECSODI, J., BOLL, W., CAN-TELL, K., and WEISSMANN, C. (1980). Synthesis in E. coli of a polypeptide with human leukocyte interferon activity. Nature 284, 316–320.
SCHELLEKENS, H., DE REUS, A., BOLHUIS, R., FOUNTOULAKIS, M., SCHEIN, C., ECSODI, J., NAGATA, S., and WEISSMANN, C. (1981). Comparative antiviral efficiency of leukocyte and bacterially produced human α interferon in rhesus monkeys. Nature 292, 775–776.
GRESSER, I., BANDU, M.T., BROUTY-BOYE, D., and TOVEY, M. (1974). Pronounced antiviral activity of human interferon on bovine and porcine cells. Nature 251, 543–545.
DAGENAIS, L., PASTORET, P.-P., VANDEN BROECKE, C., and WERENNE, J. (1981). Susceptibility of bovine rotavirus to interferon. Arch. Virol. 70, 377–379.
STREULI, M., HALL, A., BOLL, W., STEWART, W.E., II, NAGATA, S., and WEISSMANN, C. (1981). Target cell specificity of two species of human interferon produced in E. coli and of hybrid molecules derived from them. Proc. Natl. Acad. Sci. USA 78, 2848–2852.
STEWART W.E., II (1979). The Interferon System. Springer-Verlag, Vienna, New York.
WERENNE, J., PASTORET, P.-P., VANDEN BROECKE, C., SCHWERS, A., GOOSSENS, A., BUGYAKI, L., and MAENHOUDT, M. (1983). Bacterially produced interferon as an antiviral in the bovine species, in: The Biology of the Interferon System. E. De Maeyer and H. Schellekens (eds.). Elsevier Science Publishers, New York. pp. 419–424.
GOOSSENS, A., SCHWERS, A., VANDEN BROECKE, C., MAENHOUDT, M., BUGYAKI, L., PASTORET, P.-P., and WERENNE, J. (1982). Antiviral efficiency of interferon in the bovine species: preliminary data on the activity in calves of bacterially produced interferon. Arch. Int. Physiol. Biochimie 90(4), B193.
SCHWERS, A., GOOSSENS, A., VANDEN BROECKE, C., MAENHOUDT, M., BUGYAKI, L., PASTORET, P.-P., and WERENNE, J. (1983). Antiviral efficiency of bacterially produced human interferon in the bovine species. EEC workshop on interferon and non-specific immunity (in press).
INGIMARSSON, S., CANTELL, K., and STRANDER, S. (1979). Side effects of long term treatment with human leukocyte interferon. J. Infect. Dis. 140, 560–563.
SCOTT, G.M., SECHER, D.S., FLOWERS, D., BATE, J., CANTELL, K., and TYRELL, D.A.J. (1981). The toxicity of interferon, in: Antiviral Research Abstr. 1, No. 1, Special Abstract issue, 63, p. 46.
CANTELL, K. and PYHALA, L., (1976). Pharmacokinetics of human leukocyte interferon. J. Infect. Dis. 133, Suppl., A6-A12.
EDY, V.G., BILLIAU, A., and DE SOMER, P. (1976). Comparison of rates of clearance of human fibroblast and leukocyte interferon from the circulatory system of rabbits. J. Infect. Dis. 133, Suppl., A18-A21.
BILLIAU, A., HEREMANS, H., VERVERKEN, D., VAN DAMME, J., CARTON, H., and DE SOMER, P. (1981). Tissue distribution of human interferons after exogenous administration in rabbits, monkeys and mice. Arch. Virol. 68, 19–25.
BREINIG, M.C., HO, M., WHITE, L., ARMSTRONG, J.A., PAZIN, G.J., HAVERKOS, H.W., and CANTELL, K. (1982). Effect of prolonged administration of interferon-alpha on pharmacokinetics, fever, lymphocyte proliferative response and NK cells activity. J. IFN Res. 2, 195–207.
SCHWERS, A., VANDEN BROECKE, C., GOOSSENS, A., MAENHOUDT, M., BUGYAKI, L., PASTORET, P.-P., and WERENNE, J. (1982). Administration of human interferon to young calves: circulating antiviral activity and biological response of the host. Arch. Int. Physiol. Biochimie 90(4), B214.
JORDAN, G.W., FRIED, R.P., and MERIGAN, T. (1974). Administration of human leukocyte interferon in herpes Zoster. I. Safety, circulating antiviral activity and host responses to infection. J. Infect. Dis. 130(1), 56–62.
SARKAR, F.H. (1982). Pharmacokinetic comparison of leukocyte and E. coli derived human interferon type alpha. Antiviral Res. 2, 103–106.
SCHWERS, A., PASTORET, P.-P., MAENHOUDT, M., DAGENAIS, L., VANDEN BROECKE, C., GOOSSENS, A., and WERENNE, J. (1983). Tentative de reproduction expérimentale de la diarrhée à rotavirus chez des veaux nouveau-nés privés de colostrum. Ann. Rech. Vét. 14, 265–270.
VANDEN BROECKE, C., SCHWERS, A., DAGENAIS, L., GOOSSENS, A., MAENHOUDT, M., PASTORET, P.-P., and WERENNE, J. (1984). Interferon response in colostrum-deprived newborn calves infected with bovine rotavirus: its possible role in the control of the pathogenicity. Ann Rech. Vét. 15(1), 29–34.
TOMPKINS, M.B. and CUMMINS J.M. (1982). Response of feline leukemia virus-induced non-regenerative anemia to oral administration of an interferon-containing preparation. Feline Practice 12(3), 6–15.
GOOSSENS, A., SCHWERS, A., VANDEN BROECKE, C., DAGENAIS, L., MAENHOUDT, M., DUWYN, R., VAN CAMP, B., PASTORET, P.-P., and WERENNE, J. (1983). Sensibilité des virus de la rhinotrachéite infectieuse bovine (Bovine herpesvirus I) et de la maladie d'Aujeszky (Suid herpesvirus I) à l'interféron humain produit par des bactéries (Hu-IFNα2). Ann Méd. Vét. 127, 135–139.